Morrison & Foerster partners Jordan Eth and David J. Wiener have entered appearances for Gingko Bioworks, a biotech company that went public via SPAC merger with Soaring Eagle Acquisition Corp., and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 20 in California Northern District Court by Wolf Haldenstein Adler Freeman & Herz; Rigrodsky Law; and the Grabar Law Office on behalf of Eric Bowers, accuses Soaring Eagle and members of its board of directors of filing a false and misleading proxy statement touting Gingko’s foundry revenue. According to the suit, the defendants failed to disclose that the overwhelming majority of Gingko’s revenues were derived from circular transactions with entities that were funded or controlled by Gingko. The case, assigned to U.S. Magistrate Judge Kandis A. Westmore, is 4:23-cv-05396, Bowers et al v. Kelly et al.
This suit was surfaced by Law.com Radar, ALM’s source for immediate alerting on just filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be first to know about new suits in your region, practice area or client sector. Read the complaint here:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
